Dr. Stavros Melemenidis | Nanotheranostics Awards | Best Researcher Award

Dr. Stavros Melemenidis , Stanford University School of Medicine , United States

Stavros Melemenidis, DPhil, is a distinguished figure in the field of Radiation Oncology, currently serving as Director of Pre-clinical Radiotherapy and Research Scientist at Stanford University’s Department of Radiation Oncology in Stanford, CA, USA. He completed his DPhil in Radiation Biology at the University of Oxford, where his research focused on molecular targeted imaging methods for lung metastasis and angiogenesis detection. Dr. Melemenidis holds a diverse educational background including degrees from UCLA and the University of Liverpool. His expertise spans preclinical radiotherapy, ultra-high dose-rate irradiation experiments, and the development of advanced imaging probes and animal models for cancer research. Dr. Melemenidis is recognized for his contributions to radiation therapy and imaging sciences, employing innovative techniques to advance cancer treatment and research.

Professional Profile:

Scopus

🎓Education:

Stavros Melemenidis, DPhil, has pursued an extensive educational journey encompassing a diverse array of disciplines. He earned his DPhil in Radiation Biology from the University of Oxford, UK, focusing on the development of molecular targeted imaging methods for the detection of lung metastasis and angiogenesis. His academic credentials also include a Cert. in Medical Physics from UCLA, USA, an M.Sc. in Radiation Biology from the University of Oxford, UK, and an M.Sc. in Radiometrics; Instrumentation and Modelling from the University of Liverpool, UK. Dr. Melemenidis began his academic path with a B.Sc. in Physics: Medical Applications from the University of Liverpool and an A.Eng. in PC Systems and Peripheral Equipment from IIEK Neapoleos, Technical College, Greece. This diverse educational background has equipped him with expertise spanning radiation biology, medical physics, instrumentation, and modelling, contributing significantly to his research and leadership roles in the field of Radiation Oncology at Stanford University.

🏢Work Experience:

Stavros Melemenidis, DPhil, holds key positions in the field of Radiation Oncology at Stanford University in Stanford, CA, USA. Since January 2023, he has served as the Director of Pre-clinical Radiotherapy within the Department of Radiation Oncology, overseeing advanced research initiatives. Prior to this role, Dr. Melemenidis has been integral to the Division of Radiation Therapy as a Research Scientist since February 2020, contributing to innovative studies in radiation oncology. His earlier career includes impactful roles as a Postdoctoral Fellow at Stanford University from February 2016 to June 2020, where he focused on developing in vivo mouse tumor models and integrating imaging techniques with radiotherapy and immunotherapy. Previously, he was a Postdoctoral Fellow at the University of Oxford’s Department of Radiation Oncology from January 2015 to September 2015, conducting research on novel imaging probes for metastasis and angiogenesis detection. These experiences underscore Dr. Melemenidis’s dedication to advancing preclinical and clinical applications in radiation oncology through pioneering research and leadership.

Publication Top Notes:

Human enteroids as a tool to study conventional and ultra-high dose rate radiation
- Authors: Klett, K.C., Martin-Villa, B.C., Villarreal, V.S., Loo Jr, B.W., Heilshorn, S.C.
- Citations: 1
Real-time optical oximetry during FLASH radiotherapy using a phosphorescent nanoprobe
- Authors: Ha, B., Liang, K., Liu, C., Loo, B.W., Pratx, G.
- Citations: 4
Endogenous Retroviral Elements Generate Pathologic Neutrophils in Pulmonary Arterial Hypertension
- Authors: Taylor, S., Isobe, S., Cao, A., Snyder, M.P., Rabinovitch, M.
- Citations: 10
Design and validation of a dosimetric comparison scheme tailored for ultra-high dose-rate electron beams to support multicenter FLASH preclinical studies
- Authors: Jorge, P.G., Melemenidis, S., Grilj, V., Loo, B.W., Bailat, C.
- Citations: 9

Prof. Jamal Sabir , King Abdulaziz University , Saudi Arabia

Jamal Sabir M Sabir, a Saudi Arabian native born in Taif, holds a distinguished academic background. He earned his Bachelor’s degree in Biology (Zoology) from King Abdulaziz University in 1980, followed by a Master’s degree in Biology (Genetics) from the same institution in 1984. His academic journey culminated in a Ph.D. in Genetics and Biotechnology from Sussex University, UK, in 1992. Dr. Sabir’s career progression reflects his dedication to academia, starting as a Demonstrator at King Abdulaziz University in 1980 and rising to the rank of Professor in 2014. His scientific pursuits encompass diverse areas, including the induction of genetic mutations, genotoxicity studies of pesticides and heavy metals, and biotechnology research. Dr. Sabir has supervised numerous postgraduate projects, focusing on mutagenic effects, cytogenetics, molecular evaluations, and genomic analyses. His contributions extend to bioremediation efforts for oil pollutants and the molecular genetic study of human breast cancer. Dr. Sabir’s extensive scientific activities underscore his commitment to advancing genetic research and biotechnology in Saudi Arabia and beyond.

Professional Profile:

Scopus

Education:

Jamal Sabir M Sabir earned his Bachelor’s degree in Biology (Zoology) from King Abdulaziz University in Saudi Arabia in 1980. He continued his studies at the same institution, obtaining a Master’s degree in Biology (Genetics) in 1984. Dr. Sabir then pursued his Ph.D. in Genetics and Biotechnology at Sussex University in Brighton, UK, completing it in 1992

Work Experience:

Dr. Jamal Sabir M Sabir’s career at King Abdulaziz University in Saudi Arabia began in 1980 when he was appointed as a Demonstrator in the Faculty of Science. He advanced to the position of Lecturer in 1986. In 1992, Dr. Sabir was promoted to Assistant Professor, followed by a promotion to Associate Professor in 2001. His academic achievements and dedication to research and teaching led to his promotion to full Professor in 2014.

Publication Top Notes:

Synthesis of biocomposites from microalgal peptide incorporated polycaprolactone/κ-carrageenan nanofibers and their antibacterial and wound healing property
- Authors: Raghunathan, S., Kandasamy, S., Balakrishna Pillai, A., Kim, J.-W., Davoodbasha, M.
- Journal: International Journal of Pharmaceutics, 2024
Synthesis and characterization of hydroxy propyl methyl Cellulose/Copper nanobiocomposites for antibacterial and antioxidant smart materials
- Authors: Davoodbasha, M., Raghunathan, S., Mohammed Yasin, A., Lee, S.-Y., Kim, J.-W.
- Journal: Journal of Molecular Liquids, 2024
Identification and Characterization of HIRIP3 as a Histone H2A Chaperone
- Authors: Ignatyeva, M., Patel, A.K.M., Ibrahim, A., Sabir, J.S.M., Hamiche, A.
- Journal: Cells, 2024
Next generation sequencing shows diversity of Omicron sub-lineages of SARS-COV2 circulating in Jeddah, Saudi Arabia
- Authors: Bouna, A., Atef, A., Al-Mahdi, H.B., Rather, I.A., Sabir, J.S.M.
- Journal: Journal of King Saud University – Science, 2024
MBD4 loss results in global reactivation of promoters and retroelements with low methylated CpG density
- Authors: Papin, C., Ibrahim, A., Sabir, J.S.M., Bronner, C., Hamiche, A.
- Journal: Journal of Experimental and Clinical Cancer Research, 2023
- Citations: 1